clenbuterol has been researched along with transforming growth factor beta in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Culmsee, C; Krieglstein, J; Schäfer, MK; Stumm, RK; Weihe, E | 1 |
| Culmsee, C; Krieglstein, J; Roth-Eichhorn, S; Zhu, Y | 1 |
| Akutsu, S; Shimada, A; Yamane, A | 1 |
| Connor, TJ; González-Reyes, RE; Griffin, EW; Harkin, A; McNamee, EN; Ryan, KJ; Ryan, KM | 1 |
4 other study(ies) available for clenbuterol and transforming growth factor beta
| Article | Year |
|---|---|
Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage.
Topics: Animals; Astrocytes; Blood Glucose; Blood Pressure; Brain; Cerebral Arteries; Cerebral Cortex; Clenbuterol; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Glial Fibrillary Acidic Protein; Growth Substances; Hippocampus; In Situ Hybridization; Infarction; Ischemia; Male; Rats; Rats, Long-Evans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transforming Growth Factor beta | 1999 |
Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-beta-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia.
Topics: Adrenergic beta-Agonists; Animals; Carrier Proteins; Clenbuterol; Gene Expression; Hippocampus; Intracellular Signaling Peptides and Proteins; Ischemic Attack, Transient; Latent TGF-beta Binding Proteins; Male; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Fibroblast Growth Factors; Hepatocyte Growth Factor; Hypertrophy; Immunohistochemistry; Male; Masseter Muscle; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Up-Regulation | 2006 |
Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Brain; Cerebral Cortex; Clenbuterol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hippocampus; Idazoxan; Injections, Intraperitoneal; Interleukin-10; Interleukin-4; Male; Morpholines; Norepinephrine; Phosphorylation; Propranolol; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-2; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Transforming Growth Factor beta | 2010 |